Yusuke Nakauchi

769 total citations
23 papers, 484 citations indexed

About

Yusuke Nakauchi is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Yusuke Nakauchi has authored 23 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 8 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Yusuke Nakauchi's work include Acute Myeloid Leukemia Research (11 papers), CAR-T cell therapy research (5 papers) and Protein Degradation and Inhibitors (4 papers). Yusuke Nakauchi is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), CAR-T cell therapy research (5 papers) and Protein Degradation and Inhibitors (4 papers). Yusuke Nakauchi collaborates with scholars based in United States, Japan and India. Yusuke Nakauchi's co-authors include Hiromitsu Nakauchi, Ravindra Majeti, Adam C. Wilkinson, Chen‐Yi Lai, Jun Ooehara, Jonathan K. Pritchard, Xun Lan, Ryō Yamamoto, Thomas Köhnke and Melissa Stafford and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Nature Biotechnology.

In The Last Decade

Yusuke Nakauchi

16 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yusuke Nakauchi United States 10 269 256 122 90 76 23 484
Norimasa Yamasaki Japan 14 290 1.1× 210 0.8× 97 0.8× 50 0.6× 86 1.1× 32 487
Shweta Singh United States 11 162 0.6× 138 0.5× 94 0.8× 85 0.9× 109 1.4× 17 343
Seishi Ogawa Japan 5 285 1.1× 347 1.4× 118 1.0× 45 0.5× 95 1.3× 11 508
Jeffrey M. Bernitz United States 9 324 1.2× 330 1.3× 250 2.0× 48 0.5× 80 1.1× 14 659
Maja Jankovic United States 5 342 1.3× 295 1.2× 217 1.8× 39 0.4× 74 1.0× 8 574
Christopher Day Canada 4 292 1.1× 240 0.9× 181 1.5× 47 0.5× 56 0.7× 7 528
Stefania Militi Italy 8 171 0.6× 178 0.7× 144 1.2× 139 1.5× 58 0.8× 12 427
Weiqi Huang United States 16 450 1.7× 177 0.7× 208 1.7× 172 1.9× 86 1.1× 36 689
Salima Janmohamed Canada 6 259 1.0× 145 0.6× 175 1.4× 124 1.4× 39 0.5× 6 463
Bauke de Boer Netherlands 9 261 1.0× 132 0.5× 72 0.6× 67 0.7× 37 0.5× 13 394

Countries citing papers authored by Yusuke Nakauchi

Since Specialization
Citations

This map shows the geographic impact of Yusuke Nakauchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuke Nakauchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuke Nakauchi more than expected).

Fields of papers citing papers by Yusuke Nakauchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusuke Nakauchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuke Nakauchi. The network helps show where Yusuke Nakauchi may publish in the future.

Co-authorship network of co-authors of Yusuke Nakauchi

This figure shows the co-authorship network connecting the top 25 collaborators of Yusuke Nakauchi. A scholar is included among the top collaborators of Yusuke Nakauchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusuke Nakauchi. Yusuke Nakauchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karigane, Daiki, Amy C. Fan, Toshinobu Nishimura, et al.. (2025). Intra-Leukemic Interferon Signaling Suppresses Expansion and Mediates Chemoresistance in Human AML. Blood Cancer Discovery. 7(1). 68–84.
2.
Charlesworth, Carsten T., Anais K. Amaya, Sriram Vaidyanathan, et al.. (2025). Highly efficient in vivo hematopoietic stem cell transduction using an optimized self-complementary adeno-associated virus. Molecular Therapy — Methods & Clinical Development. 33(1). 101438–101438.
3.
Nishimura, Toshinobu, Laura Amaya, Jonas L. Fowler, et al.. (2025). Development of iPSC-derived T cells targeting EGFR neoantigens in non-small cell lung cancer. Molecular Therapy — Methods & Clinical Development. 33(3). 101517–101517.
4.
Suchy, Fabian P., Daiki Karigane, Yusuke Nakauchi, et al.. (2024). Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors. Nature Biotechnology. 43(2). 204–213. 25 indexed citations
5.
Wang, Wenqing, Thomas P. Mathews, Andrew DeVilbiss, et al.. (2024). Failure of metabolic checkpoint control during late-stage granulopoiesis drives neutropenia in reticular dysgenesis. Blood. 144(26). 2718–2734.
6.
Luca, Bogdan, Benjamin Thomas, Molly Javier Uyeda, et al.. (2024). AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML. Leukemia. 38(6). 1246–1255. 6 indexed citations
7.
Landberg, Niklas, Thomas Köhnke, Yang Feng, et al.. (2023). IDH1 -Mutant Preleukemic Hematopoietic Stem Cells Can Be Eliminated by Inhibition of Oxidative Phosphorylation. Blood Cancer Discovery. 5(2). 114–131. 9 indexed citations
8.
9.
Fan, Amy C., Daiki Karigane, Feifei Zhao, et al.. (2023). BCOR Loss Confers Increased Stemness and Partially Rescues RUNX1-Deficient Phenotypes in Human Hematopoietic Stem and Progenitor Cells. Blood. 142(Supplement 1). 946–946.
10.
Fan, Amy C., Yusuke Nakauchi, Lawrence Bai, et al.. (2023). RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibition. Journal of Clinical Investigation. 133(19). 4 indexed citations
11.
Nakauchi, Yusuke, et al.. (2023). Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis. Journal of Visualized Experiments. 1 indexed citations
12.
Thomas, Danièl, Manhong Wu, Yusuke Nakauchi, et al.. (2022). Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability. Cancer Discovery. 13(2). 496–515. 39 indexed citations
13.
Bruyneel, Arne A.N., Dhanir Tailor, Mallesh Pandrala, et al.. (2022). Reengineering Ponatinib to Minimize Cardiovascular Toxicity. Cancer Research. 82(15). 2777–2791. 14 indexed citations
14.
Landberg, Niklas, Yusuke Nakauchi, Amy C. Fan, et al.. (2022). Targeting IDH1-Mutated Pre-Leukemic Hematopoietic Stem Cells in Myeloid Disease, Including CCUS and AML. Blood. 140(Supplement 1). 2234–2235. 2 indexed citations
15.
Zhang, Haijiao, Yusuke Nakauchi, Thomas Köhnke, et al.. (2020). Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia. Nature Cancer. 1(8). 826–839. 121 indexed citations
16.
Zhang, Tian Yi, Thomas Köhnke, Danièl Thomas, et al.. (2020). Enasidenib drives human erythroid differentiation independently of isocitrate dehydrogenase 2. Journal of Clinical Investigation. 130(4). 1843–1849. 21 indexed citations
17.
Yamamoto, Ryō, Adam C. Wilkinson, Jun Ooehara, et al.. (2018). Large-Scale Clonal Analysis Resolves Aging of the Mouse Hematopoietic Stem Cell Compartment. Cell stem cell. 22(4). 600–607.e4. 141 indexed citations
18.
Matsuoka, Shuji, Yasuyuki Ishii, Atsuhito Nakao, et al.. (2016). Establishment of a Therapeutic Anti-Pan HLA-Class II Monoclonal Antibody That Directly Induces Lymphoma Cell Death via Large Pore Formation. PLoS ONE. 11(3). e0150496–e0150496. 3 indexed citations
19.
Ando, Miki, Toshinobu Nishimura, Satoshi Yamazaki, et al.. (2015). A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy. Stem Cell Reports. 5(4). 597–608. 66 indexed citations
20.
Nakauchi, Yusuke, Hiroshi Takase, Sunao Sugita, et al.. (2010). Concurrent administration of intravenous systemic and intravitreal methotrexate for intraocular lymphoma with central nervous system involvement. International Journal of Hematology. 92(1). 179–185. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norimasa Yamasaki Breakdown of academic impact, for papers by Shweta Singh Breakdown of academic impact, for papers by Seishi Ogawa Breakdown of academic impact, for papers by Jeffrey M. Bernitz Breakdown of academic impact, for papers by Maja Jankovic Breakdown of academic impact, for papers by Christopher Day Breakdown of academic impact, for papers by Stefania Militi Breakdown of academic impact, for papers by Weiqi Huang Breakdown of academic impact, for papers by Salima Janmohamed Breakdown of academic impact, for papers by Bauke de Boer
Rankless by CCL
2026